Deep Brain Stimulation for Gait Ataxia

(DBS-Ataxia Trial)

This trial aims to determine if deep brain stimulation (DBS), a technique often used for Parkinson's disease, can benefit individuals with gait ataxia, a condition causing unsteady walking due to brain coordination issues. The study will assess the safety and practicality of using DBS on the cerebellum, the brain region controlling movement, for those whose ataxia has not improved with other treatments. This trial suits patients aged 20-70 with primary ataxia and no other neurological issues. Participants must attend all appointments and adhere to study protocols. As an unphased trial, this study offers patients the chance to contribute to groundbreaking research that could lead to new treatment options for ataxia.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that deep brain stimulation (DBS) for cerebellar ataxia is generally safe and well-tolerated. Several studies have examined its safety when targeting the cerebellum, the part of the brain that helps control movement. One study found that DBS in the dentate nucleus (a specific area in the cerebellum) was safe and helped reduce tremors linked to cerebellar disorders. Another study observed that five patients with cerebellar ataxia experienced modest improvements after receiving DBS.

Unlike standard treatments for gait ataxia, which often focus on physical therapy and medication to manage symptoms, cerebellar deep brain stimulation directly targets the brain's cerebellum to potentially improve motor function. This technique involves implanting electrodes in the brain to modulate neural activity, offering a new way to address the underlying neural dysfunction rather than just alleviating symptoms. Researchers are excited about this approach because it could lead to more significant and lasting improvements in balance and coordination for patients, potentially transforming their quality of life.

Studies have shown that deep brain stimulation (DBS) targeting the cerebellum can help improve walking difficulties. Several small studies and case reports have found modest improvements in symptoms like balance and walking. In one study, five patients with cerebellar ataxia noticed better movement after receiving DBS. Another study found similar benefits for patients with spinocerebellar ataxia, a genetic disorder affecting movement. These findings suggest that DBS may help manage walking difficulties by stimulating specific brain areas involved in movement coordination. Participants in this trial will receive cerebellar DBS to evaluate its effectiveness for gait ataxia.¹³⁴⁵⁶